RBIS

Across TCGA pan-cancer cohorts, RBIS Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RBIS data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RBIS Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RBIS expression acts as an unfavorable survival marker.

HNSC are the cancer types where RBIS Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	III,IV	0.155	0.656	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RBIS–HNSC (OS)

Open the HNSC breakdown →